ZIP It: Neural Silencing Is an Additional Effect of the PKM-Zeta Inhibitor Zeta-Inhibitory Peptide.
Protein kinase M ζ (PKMζ), an atypical isoform of protein kinase C, has been suggested to be necessary and sufficient for the maintenance of long-term potentiation (LTP) and long-term memory (LTM). This evidence is heavily based on the use of ζ inhibitory peptide (ZIP), a supposed specific inhibitor of PKMζ that interferes with both LTP and LTM. Problematically, both LTP and LTM are unaffected in both constitutive and conditional PKMζ knock-out mice, yet both are still impaired by ZIP application, suggesting a nonspecific mechanism of action. Because translational interference can disrupt neural activity, we assessed network activity after a unilateral intrahippocampal infusion of ZIP in anesthetized rats. ZIP profoundly reduced spontaneous hippocampal local field potentials, comparable in magnitude to infusions of lidocaine, but with a slower onset and longer duration. Our results highlight a serious confound in interpreting the behavioral effects of ZIP. We suggest that future molecular approaches in neuroscience consider the intervening level of cellular and systems neurophysiology before claiming influences on behavior.



Long-term memory in the brain is thought to arise from a sustained molecular process that can maintain changes in synaptic plasticity. A so-called candidate for the title of "the memory molecule" is protein kinase M ζ (PKMζ), mainly because its inhibition by ζ inhibitory peptide (ZIP) interferes with previously established synaptic plasticity and memory. We show that brain applications of ZIP that can impair memory actually profoundly suppress spontaneous brain activity directly or can cause abnormal seizure activity. We suggest that normal brain activity occurring after learning may be a more primary element of memory permanence.
Neuroscience and Mental Health Institute, University of Alberta, Alberta, Edmonton T6G 2E1, Canada.
Michelle J
MJ
LeBlancq
Department of Psychology, University of Alberta, Alberta, Edmonton T6G 2E9, Canada, and.
Ty L
TL
McKinney
Neuroscience and Mental Health Institute, University of Alberta, Alberta, Edmonton T6G 2E1, Canada, Department of Psychology, University of Alberta, Alberta, Edmonton T6G 2E9, Canada, and Department of Physiology, University of Alberta, Alberta, Edmonton T6G 2H7, Canada clayton.dickson@ualberta.ca.
Clayton T
0000-0002-3849-8110
CT
Dickson
D000367:Age Factors; D000704:Analysis of Variance; D000779:Anesthetics, Local / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D057846:Cell-Penetrating Peptides; D007839:Functional Laterality; D006624:Hippocampus / Q000187:drug effects* / Q000502:physiology; D008012:Lidocaine / Q000494:pharmacology; D055666:Lipopeptides / Q000494:pharmacology*; D017774:Long-Term Potentiation / Q000187:drug effects* / Q000502:physiology; D008297:Male; D009433:Neural Inhibition / Q000187:drug effects*; D009474:Neurons / Q000187:drug effects*; D011493:Protein Kinase C / Q000378:metabolism / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D011930:Reaction Time / Q000187:drug effects; D013997:Time Factors
D000779:Anesthetics, Local; D057846:Cell-Penetrating Peptides; D055666:Lipopeptides; C568285:zeta-inhibitory peptide; D008012:Lidocaine; D011493:Protein Kinase C
hippocampus; memory consolidation; neural inactivation; protein kinase M zeta; spontaneous brain rhythms